TY  - JOUR
AU  - Meslé, Margaux M. I.
AU  - Sinnathamby, Mary
AU  - Mook, Piers
AU  - Pebody, Richard
AU  - Protić, Jelena
PY  - 2023
UR  - http://intor.torlakinstitut.com/handle/123456789/846
AB  - Background The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in early 2020 and subsequent implementation of public health and social measures (PHSM) disrupted the epidemiology of respiratory viruses. This work describes the epidemiology of respiratory syncytial virus (RSV) observed during two winter seasons (weeks 40–20) and inter-seasonal periods (weeks 21–39) during the pandemic between October 2020 and September 2022. Methods Using data submitted to The European Surveillance System (TESSy) by countries or territories in the World Health Organization (WHO) European Region between weeks 40/2020 and 39/2022, we aggregated country-specific weekly RSV counts of sentinel, non-sentinel and Severe Acute Respiratory Infection (SARI) surveillance specimens and calculated percentage positivity. Results for both 2020/21 and 2021/22 seasons and inter-seasons were compared with pre-pandemic 2016/17 to 2019/20 seasons and inter-seasons. Results Although more specimens were tested than in pre-COVID-19 pandemic seasons, very few RSV detections were reported during the 2020/21 season in all surveillance systems. During the 2021 inter-season, a gradual increase in detections was observed in all systems. In 2021/22, all systems saw early peaks of RSV infection, and during the 2022 inter-seasonal period, patterns of detections were closer to those seen before the COVID-19 pandemic. Conclusion RSV surveillance continued throughout the COVID-19 pandemic, with an initial reduction in transmission, followed by very high and out-of-season RSV circulation (summer 2021) and then an early start of the 2021/22 season. As of the 2022/23 season, RSV circulation had not yet normalised.
PB  - Wiley
T2  - Influenza and Other Respiratory Viruses
T1  - Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022
IS  - 11
SP  - e13219
VL  - 17
DO  - 10.1111/irv.13219
ER  - 

@article{
author = "Meslé, Margaux M. I. and Sinnathamby, Mary and Mook, Piers and Pebody, Richard and Protić, Jelena",
year = "2023",
abstract = "Background The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in early 2020 and subsequent implementation of public health and social measures (PHSM) disrupted the epidemiology of respiratory viruses. This work describes the epidemiology of respiratory syncytial virus (RSV) observed during two winter seasons (weeks 40–20) and inter-seasonal periods (weeks 21–39) during the pandemic between October 2020 and September 2022. Methods Using data submitted to The European Surveillance System (TESSy) by countries or territories in the World Health Organization (WHO) European Region between weeks 40/2020 and 39/2022, we aggregated country-specific weekly RSV counts of sentinel, non-sentinel and Severe Acute Respiratory Infection (SARI) surveillance specimens and calculated percentage positivity. Results for both 2020/21 and 2021/22 seasons and inter-seasons were compared with pre-pandemic 2016/17 to 2019/20 seasons and inter-seasons. Results Although more specimens were tested than in pre-COVID-19 pandemic seasons, very few RSV detections were reported during the 2020/21 season in all surveillance systems. During the 2021 inter-season, a gradual increase in detections was observed in all systems. In 2021/22, all systems saw early peaks of RSV infection, and during the 2022 inter-seasonal period, patterns of detections were closer to those seen before the COVID-19 pandemic. Conclusion RSV surveillance continued throughout the COVID-19 pandemic, with an initial reduction in transmission, followed by very high and out-of-season RSV circulation (summer 2021) and then an early start of the 2021/22 season. As of the 2022/23 season, RSV circulation had not yet normalised.",
publisher = "Wiley",
journal = "Influenza and Other Respiratory Viruses",
title = "Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022",
number = "11",
pages = "e13219",
volume = "17",
doi = "10.1111/irv.13219"
}

Meslé, M. M. I., Sinnathamby, M., Mook, P., Pebody, R.,& Protić, J.. (2023). Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022. in Influenza and Other Respiratory Viruses
Wiley., 17(11), e13219.
https://doi.org/10.1111/irv.13219

Meslé MMI, Sinnathamby M, Mook P, Pebody R, Protić J. Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022. in Influenza and Other Respiratory Viruses. 2023;17(11):e13219.
doi:10.1111/irv.13219 .

Meslé, Margaux M. I., Sinnathamby, Mary, Mook, Piers, Pebody, Richard, Protić, Jelena, "Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022" in Influenza and Other Respiratory Viruses, 17, no. 11 (2023):e13219,
https://doi.org/10.1111/irv.13219 . .

TY  - JOUR
AU  - Mögling, Ramona
AU  - Reimerink, Johan
AU  - Stanoeva, Kamelia R.
AU  - Keramarou, Maria
AU  - Guiomar, Raquel
AU  - Costa, Inês
AU  - Haveri, Anu
AU  - Holzer, Barbara
AU  - Korukluoğlu, Gülay
AU  - Nguyen, Trung
AU  - Pakarna, Gatis
AU  - Pancer, Katarzyna
AU  - Trilar, Katarina Prosenc
AU  - Protić, Jelena
AU  - Stojanović, Marijana
AU  - De Santis, Riccardo
AU  - Lista, Florigio
AU  - Vremera, Teodora
AU  - Leustean, Mihaela
AU  - Pistol, Adriana
AU  - Zelena, Hana
AU  - Reusken, Chantal
AU  - Broberg, Eeva K.
PY  - 2023
UR  - http://intor.torlakinstitut.com/handle/123456789/805
AB  - One consequence of the ongoing coronavirus disease pandemic was the rapid development of both in-house and commercial serological assays detecting anti-SARS-CoV-2 antibodies, in an effort to reliably detect acute and past SARS-CoV-2 infections. It is crucial to evaluate the quality of these serological tests and consequently the sero-epidemiological studies that are performed with the respective tests. Here, we describe the set-up and results of a comparative study, in which a laboratory contracted by the European Centre for Disease Prevention and Control offered a centralised service to EU/EEA Member and pre-accession Member States to test representative serum specimens with known serological results, with the gold standard technique (virus neutralisation tests) to determine the presence of neutralising antibodies. Laboratories from 12 European countries shared 719 serum specimens with the contractor laboratory. We found that in-house serological tests detecting neutralising antibodies showed the highest percent agreement, both positive and negative, with the virus neutralisation test results. Despite extensive differences in virus neutralisation protocols neutralisation titres showed a strong correlation. From the commercial assays, the best positive percent agreement was found for SARS-CoV-2 IgG (sCOVG) (Siemens - Atellica IM Analyzer). Despite lower positive percent agreement of LIAISON SARS-CoV-2 TrimericS IgG kit (Diasorin Inc.), the obtained results showed relatively good correlation with neutralisation titres. The set-up of this study allowed for high comparability between laboratories and enabled laboratories that do not have the capacity or capability to perform VNTs themselves. Given the variety of in-house protocols detecting SARS-CoV-2 specific neutralising antibodies, including the virus strain, it could be of interest to select reference isolates for SARS-CoV-2 diagnostic to be made available for interested EU Member States and pre-accession countries.
PB  - Elsevier
T2  - Journal of Virological Methods
T1  - Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021
SP  - 114825
VL  - 322
DO  - 10.1016/j.jviromet.2023.114825
ER  - 

@article{
author = "Mögling, Ramona and Reimerink, Johan and Stanoeva, Kamelia R. and Keramarou, Maria and Guiomar, Raquel and Costa, Inês and Haveri, Anu and Holzer, Barbara and Korukluoğlu, Gülay and Nguyen, Trung and Pakarna, Gatis and Pancer, Katarzyna and Trilar, Katarina Prosenc and Protić, Jelena and Stojanović, Marijana and De Santis, Riccardo and Lista, Florigio and Vremera, Teodora and Leustean, Mihaela and Pistol, Adriana and Zelena, Hana and Reusken, Chantal and Broberg, Eeva K.",
year = "2023",
abstract = "One consequence of the ongoing coronavirus disease pandemic was the rapid development of both in-house and commercial serological assays detecting anti-SARS-CoV-2 antibodies, in an effort to reliably detect acute and past SARS-CoV-2 infections. It is crucial to evaluate the quality of these serological tests and consequently the sero-epidemiological studies that are performed with the respective tests. Here, we describe the set-up and results of a comparative study, in which a laboratory contracted by the European Centre for Disease Prevention and Control offered a centralised service to EU/EEA Member and pre-accession Member States to test representative serum specimens with known serological results, with the gold standard technique (virus neutralisation tests) to determine the presence of neutralising antibodies. Laboratories from 12 European countries shared 719 serum specimens with the contractor laboratory. We found that in-house serological tests detecting neutralising antibodies showed the highest percent agreement, both positive and negative, with the virus neutralisation test results. Despite extensive differences in virus neutralisation protocols neutralisation titres showed a strong correlation. From the commercial assays, the best positive percent agreement was found for SARS-CoV-2 IgG (sCOVG) (Siemens - Atellica IM Analyzer). Despite lower positive percent agreement of LIAISON SARS-CoV-2 TrimericS IgG kit (Diasorin Inc.), the obtained results showed relatively good correlation with neutralisation titres. The set-up of this study allowed for high comparability between laboratories and enabled laboratories that do not have the capacity or capability to perform VNTs themselves. Given the variety of in-house protocols detecting SARS-CoV-2 specific neutralising antibodies, including the virus strain, it could be of interest to select reference isolates for SARS-CoV-2 diagnostic to be made available for interested EU Member States and pre-accession countries.",
publisher = "Elsevier",
journal = "Journal of Virological Methods",
title = "Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021",
pages = "114825",
volume = "322",
doi = "10.1016/j.jviromet.2023.114825"
}

Mögling, R., Reimerink, J., Stanoeva, K. R., Keramarou, M., Guiomar, R., Costa, I., Haveri, A., Holzer, B., Korukluoğlu, G., Nguyen, T., Pakarna, G., Pancer, K., Trilar, K. P., Protić, J., Stojanović, M., De Santis, R., Lista, F., Vremera, T., Leustean, M., Pistol, A., Zelena, H., Reusken, C.,& Broberg, E. K.. (2023). Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021. in Journal of Virological Methods
Elsevier., 322, 114825.
https://doi.org/10.1016/j.jviromet.2023.114825

Mögling R, Reimerink J, Stanoeva KR, Keramarou M, Guiomar R, Costa I, Haveri A, Holzer B, Korukluoğlu G, Nguyen T, Pakarna G, Pancer K, Trilar KP, Protić J, Stojanović M, De Santis R, Lista F, Vremera T, Leustean M, Pistol A, Zelena H, Reusken C, Broberg EK. Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021. in Journal of Virological Methods. 2023;322:114825.
doi:10.1016/j.jviromet.2023.114825 .

Mögling, Ramona, Reimerink, Johan, Stanoeva, Kamelia R., Keramarou, Maria, Guiomar, Raquel, Costa, Inês, Haveri, Anu, Holzer, Barbara, Korukluoğlu, Gülay, Nguyen, Trung, Pakarna, Gatis, Pancer, Katarzyna, Trilar, Katarina Prosenc, Protić, Jelena, Stojanović, Marijana, De Santis, Riccardo, Lista, Florigio, Vremera, Teodora, Leustean, Mihaela, Pistol, Adriana, Zelena, Hana, Reusken, Chantal, Broberg, Eeva K., "Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021" in Journal of Virological Methods, 322 (2023):114825,
https://doi.org/10.1016/j.jviromet.2023.114825 . .

TY  - JOUR
AU  - Štrbac, Mirjana
AU  - Vuković, Vladimir
AU  - Patić, Aleksandra
AU  - Medić, Snežana
AU  - Pustahija, Tatjana
AU  - Petrović, Vladimir
AU  - Lendak, Dajana
AU  - Kosanović Ličina, Mirjana
AU  - Bakić, Marijan
AU  - Protić, Jelena
AU  - Pranjić, Nurka
AU  - Jandrić, Ljubica
AU  - Sokolovska, Nikolina
AU  - Ristić, Mioljub
PY  - 2022
UR  - http://intor.torlakinstitut.com/handle/123456789/668
AB  - Background: Large-scale epidemics of haemorrhagic fever with renal syndrome (HFRS) have been reported mostly in Asia and Europe, with around 100,000 people affected each year. In the Southeast Europe, Balkan region, HFRS is endemic disease with approximately 100 cases per year. Our aim was to describe epidemiological characteristics of HFRS in five Western Balkan (WB) countries and to describe correlation between HFRS incidence and major meteorological event that hit the area in May 2014. Methods: National surveillance data of HFRS from Bosnia and Herzegovina, Croatia, Montenegro, North Macedonia and Serbia obtained from 1 January 2006 to 31 December 2015 were collected and analysed. Results: In a 10-year period, a total of 1,065 HFRS patients were reported in five WB countries. Cumulative incidence rate ranged from 0.05 to 15.80 per 100.000 inhabitants (in North Macedonia and Montenegro respectively). Increasing number of HFRS cases was reported with a peak incidence in three specific years (2008, 2012, and 2014). Average incidence for the entire area was higher in males than females (5.63 and 1.90 per 100.000 inhabitants respectively). Summer was the season with the highest number of cases and an average incidence rate of 1.74/100.000 inhabitants across 10-year period. Haemorrhagic fever with renal syndrome incidence was significantly increased (7.91/100.000 inhabitants) in 2014, when a few months earlier, severe floods affected several WB countries. A strong significant negative correlation (r = −.84, p < .01) between the monthly incidence of HFRS and the number of months after May's floods was demonstrated for the total area of WB. Conclusion: Our findings demonstrate that the HFRS incidence had similar distribution (general, age, sex and seasonality) across majority of the included countries. Summer was the season with the highest recorded incidence. Common epidemic years were detected in all observed countries as well as a negative correlation between the monthly incidence of HFRS and the number of months after May's cyclone.
PB  - Wiley
T2  - Zoonoses and Public Health
T1  - Epidemiological study on the incidence of haemorrhagic fever with renal syndrome in five Western Balkan countries for a 10-year period: 2006–2015
EP  - 206
IS  - 3
SP  - 195
VL  - 69
DO  - 10.1111/zph.12908
ER  - 

@article{
author = "Štrbac, Mirjana and Vuković, Vladimir and Patić, Aleksandra and Medić, Snežana and Pustahija, Tatjana and Petrović, Vladimir and Lendak, Dajana and Kosanović Ličina, Mirjana and Bakić, Marijan and Protić, Jelena and Pranjić, Nurka and Jandrić, Ljubica and Sokolovska, Nikolina and Ristić, Mioljub",
year = "2022",
abstract = "Background: Large-scale epidemics of haemorrhagic fever with renal syndrome (HFRS) have been reported mostly in Asia and Europe, with around 100,000 people affected each year. In the Southeast Europe, Balkan region, HFRS is endemic disease with approximately 100 cases per year. Our aim was to describe epidemiological characteristics of HFRS in five Western Balkan (WB) countries and to describe correlation between HFRS incidence and major meteorological event that hit the area in May 2014. Methods: National surveillance data of HFRS from Bosnia and Herzegovina, Croatia, Montenegro, North Macedonia and Serbia obtained from 1 January 2006 to 31 December 2015 were collected and analysed. Results: In a 10-year period, a total of 1,065 HFRS patients were reported in five WB countries. Cumulative incidence rate ranged from 0.05 to 15.80 per 100.000 inhabitants (in North Macedonia and Montenegro respectively). Increasing number of HFRS cases was reported with a peak incidence in three specific years (2008, 2012, and 2014). Average incidence for the entire area was higher in males than females (5.63 and 1.90 per 100.000 inhabitants respectively). Summer was the season with the highest number of cases and an average incidence rate of 1.74/100.000 inhabitants across 10-year period. Haemorrhagic fever with renal syndrome incidence was significantly increased (7.91/100.000 inhabitants) in 2014, when a few months earlier, severe floods affected several WB countries. A strong significant negative correlation (r = −.84, p < .01) between the monthly incidence of HFRS and the number of months after May's floods was demonstrated for the total area of WB. Conclusion: Our findings demonstrate that the HFRS incidence had similar distribution (general, age, sex and seasonality) across majority of the included countries. Summer was the season with the highest recorded incidence. Common epidemic years were detected in all observed countries as well as a negative correlation between the monthly incidence of HFRS and the number of months after May's cyclone.",
publisher = "Wiley",
journal = "Zoonoses and Public Health",
title = "Epidemiological study on the incidence of haemorrhagic fever with renal syndrome in five Western Balkan countries for a 10-year period: 2006–2015",
pages = "206-195",
number = "3",
volume = "69",
doi = "10.1111/zph.12908"
}

Štrbac, M., Vuković, V., Patić, A., Medić, S., Pustahija, T., Petrović, V., Lendak, D., Kosanović Ličina, M., Bakić, M., Protić, J., Pranjić, N., Jandrić, L., Sokolovska, N.,& Ristić, M.. (2022). Epidemiological study on the incidence of haemorrhagic fever with renal syndrome in five Western Balkan countries for a 10-year period: 2006–2015. in Zoonoses and Public Health
Wiley., 69(3), 195-206.
https://doi.org/10.1111/zph.12908

Štrbac M, Vuković V, Patić A, Medić S, Pustahija T, Petrović V, Lendak D, Kosanović Ličina M, Bakić M, Protić J, Pranjić N, Jandrić L, Sokolovska N, Ristić M. Epidemiological study on the incidence of haemorrhagic fever with renal syndrome in five Western Balkan countries for a 10-year period: 2006–2015. in Zoonoses and Public Health. 2022;69(3):195-206.
doi:10.1111/zph.12908 .

Štrbac, Mirjana, Vuković, Vladimir, Patić, Aleksandra, Medić, Snežana, Pustahija, Tatjana, Petrović, Vladimir, Lendak, Dajana, Kosanović Ličina, Mirjana, Bakić, Marijan, Protić, Jelena, Pranjić, Nurka, Jandrić, Ljubica, Sokolovska, Nikolina, Ristić, Mioljub, "Epidemiological study on the incidence of haemorrhagic fever with renal syndrome in five Western Balkan countries for a 10-year period: 2006–2015" in Zoonoses and Public Health, 69, no. 3 (2022):195-206,
https://doi.org/10.1111/zph.12908 . .

TY  - JOUR
AU  - Janković, Marko
AU  - Knežević, Aleksandra
AU  - Todorović, Milena
AU  - Đunić, Irena
AU  - Mihaljević, Biljana
AU  - Soldatović, Ivan
AU  - Protić, Jelena
AU  - Miković, Nevenka
AU  - Stoiljković, Vera
AU  - Jovanović, Tanja
PY  - 2022
UR  - http://intor.torlakinstitut.com/handle/123456789/629
AB  - Although cytomegalovirus (CMV) is not considered tumorigenic, there is evidence for its oncomodulatory effects and association with hematological neoplasms. Conversely, a number of experimental and clinical studies suggest its putative anti-tumour effect. We investigated the potential connection between chronic CMV infection in patients with B-lymphocyte (B-cell) malignancies in a retrospective single-center study and extracted relevant data on CMV prevalences and the incidences of B-cell cancers the world over.
PB  - BMC
T2  - Virology Journal
T1  - Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence
IS  - 1
SP  - 155
VL  - 19
DO  - 10.1186/s12985-022-01884-1
ER  - 

@article{
author = "Janković, Marko and Knežević, Aleksandra and Todorović, Milena and Đunić, Irena and Mihaljević, Biljana and Soldatović, Ivan and Protić, Jelena and Miković, Nevenka and Stoiljković, Vera and Jovanović, Tanja",
year = "2022",
abstract = "Although cytomegalovirus (CMV) is not considered tumorigenic, there is evidence for its oncomodulatory effects and association with hematological neoplasms. Conversely, a number of experimental and clinical studies suggest its putative anti-tumour effect. We investigated the potential connection between chronic CMV infection in patients with B-lymphocyte (B-cell) malignancies in a retrospective single-center study and extracted relevant data on CMV prevalences and the incidences of B-cell cancers the world over.",
publisher = "BMC",
journal = "Virology Journal",
title = "Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence",
number = "1",
pages = "155",
volume = "19",
doi = "10.1186/s12985-022-01884-1"
}

Janković, M., Knežević, A., Todorović, M., Đunić, I., Mihaljević, B., Soldatović, I., Protić, J., Miković, N., Stoiljković, V.,& Jovanović, T.. (2022). Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence. in Virology Journal
BMC., 19(1), 155.
https://doi.org/10.1186/s12985-022-01884-1

Janković M, Knežević A, Todorović M, Đunić I, Mihaljević B, Soldatović I, Protić J, Miković N, Stoiljković V, Jovanović T. Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence. in Virology Journal. 2022;19(1):155.
doi:10.1186/s12985-022-01884-1 .

Janković, Marko, Knežević, Aleksandra, Todorović, Milena, Đunić, Irena, Mihaljević, Biljana, Soldatović, Ivan, Protić, Jelena, Miković, Nevenka, Stoiljković, Vera, Jovanović, Tanja, "Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence" in Virology Journal, 19, no. 1 (2022):155,
https://doi.org/10.1186/s12985-022-01884-1 . .

TY  - JOUR
AU  - Fontana, Stefano
AU  - Buttinelli, Gabriele
AU  - Fiore, Stefano
AU  - Amato, Concetta
AU  - Pataracchia, Marco
AU  - Kota, Majlinda
AU  - Aćimović, Jela
AU  - Blažević, Mia
AU  - Mulaomerović, Mirsada
AU  - Nikolaeva-Glomb, Lubomira
AU  - Mentis, Andreas
AU  - Voulgari-Kokota, Androniki
AU  - Gashi, Luljeta
AU  - Kaçaniku-Gunga, Pranvera
AU  - Barbara, Christopher
AU  - Melillo, Jackie
AU  - Protić, Jelena
AU  - Filipović-Vignjević, Svetlana
AU  - O’Connor, Patrick M.
AU  - D’Alberto, Alessandra
AU  - Orioli, Riccardo
AU  - Siddu, Andrea
AU  - Saxentoff, Eugene
AU  - Stefanelli, Paola
PY  - 2022
UR  - http://intor.torlakinstitut.com/handle/123456789/618
AB  - Here we analyzed six years of acute flaccid paralysis (AFP) surveillance, from 2015 to 2020, of 10 countries linked to the WHO Regional Reference Laboratory, at the Istituto Superiore di Sanità, Italy. The analysis also comprises the polio vaccine coverage available (2015–2019) and enterovirus (EV) identification and typing data. Centralized Information System for Infectious Diseases and Laboratory Data Management System databases were used to obtain data on AFP indicators and laboratory performance and countries’ vaccine coverage from 2015 to 2019. EV isolation, identification, and typing were performed by each country according to WHO protocols. Overall, a general AFP underreporting was observed. Non-Polio Enterovirus (NPEV) typing showed a high heterogeneity: over the years, several genotypes of coxsackievirus and echovirus have been identified. The polio vaccine coverage, for the data available, differs among countries. This evaluation allows for the collection, for the first time, of data from the countries of the Balkan area regarding AFP surveillance and polio vaccine coverage. The need, for some countries, to enhance the surveillance systems and to promote the polio vaccine uptake, in order to maintain the polio-free status, is evident.
PB  - MDPI
T2  - Vaccines
T1  - Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece
IS  - 1
SP  - 44
VL  - 10
DO  - 10.3390/vaccines10010044
ER  - 

@article{
author = "Fontana, Stefano and Buttinelli, Gabriele and Fiore, Stefano and Amato, Concetta and Pataracchia, Marco and Kota, Majlinda and Aćimović, Jela and Blažević, Mia and Mulaomerović, Mirsada and Nikolaeva-Glomb, Lubomira and Mentis, Andreas and Voulgari-Kokota, Androniki and Gashi, Luljeta and Kaçaniku-Gunga, Pranvera and Barbara, Christopher and Melillo, Jackie and Protić, Jelena and Filipović-Vignjević, Svetlana and O’Connor, Patrick M. and D’Alberto, Alessandra and Orioli, Riccardo and Siddu, Andrea and Saxentoff, Eugene and Stefanelli, Paola",
year = "2022",
abstract = "Here we analyzed six years of acute flaccid paralysis (AFP) surveillance, from 2015 to 2020, of 10 countries linked to the WHO Regional Reference Laboratory, at the Istituto Superiore di Sanità, Italy. The analysis also comprises the polio vaccine coverage available (2015–2019) and enterovirus (EV) identification and typing data. Centralized Information System for Infectious Diseases and Laboratory Data Management System databases were used to obtain data on AFP indicators and laboratory performance and countries’ vaccine coverage from 2015 to 2019. EV isolation, identification, and typing were performed by each country according to WHO protocols. Overall, a general AFP underreporting was observed. Non-Polio Enterovirus (NPEV) typing showed a high heterogeneity: over the years, several genotypes of coxsackievirus and echovirus have been identified. The polio vaccine coverage, for the data available, differs among countries. This evaluation allows for the collection, for the first time, of data from the countries of the Balkan area regarding AFP surveillance and polio vaccine coverage. The need, for some countries, to enhance the surveillance systems and to promote the polio vaccine uptake, in order to maintain the polio-free status, is evident.",
publisher = "MDPI",
journal = "Vaccines",
title = "Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece",
number = "1",
pages = "44",
volume = "10",
doi = "10.3390/vaccines10010044"
}

Fontana, S., Buttinelli, G., Fiore, S., Amato, C., Pataracchia, M., Kota, M., Aćimović, J., Blažević, M., Mulaomerović, M., Nikolaeva-Glomb, L., Mentis, A., Voulgari-Kokota, A., Gashi, L., Kaçaniku-Gunga, P., Barbara, C., Melillo, J., Protić, J., Filipović-Vignjević, S., O’Connor, P. M., D’Alberto, A., Orioli, R., Siddu, A., Saxentoff, E.,& Stefanelli, P.. (2022). Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece. in Vaccines
MDPI., 10(1), 44.
https://doi.org/10.3390/vaccines10010044

Fontana S, Buttinelli G, Fiore S, Amato C, Pataracchia M, Kota M, Aćimović J, Blažević M, Mulaomerović M, Nikolaeva-Glomb L, Mentis A, Voulgari-Kokota A, Gashi L, Kaçaniku-Gunga P, Barbara C, Melillo J, Protić J, Filipović-Vignjević S, O’Connor PM, D’Alberto A, Orioli R, Siddu A, Saxentoff E, Stefanelli P. Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece. in Vaccines. 2022;10(1):44.
doi:10.3390/vaccines10010044 .

Fontana, Stefano, Buttinelli, Gabriele, Fiore, Stefano, Amato, Concetta, Pataracchia, Marco, Kota, Majlinda, Aćimović, Jela, Blažević, Mia, Mulaomerović, Mirsada, Nikolaeva-Glomb, Lubomira, Mentis, Andreas, Voulgari-Kokota, Androniki, Gashi, Luljeta, Kaçaniku-Gunga, Pranvera, Barbara, Christopher, Melillo, Jackie, Protić, Jelena, Filipović-Vignjević, Svetlana, O’Connor, Patrick M., D’Alberto, Alessandra, Orioli, Riccardo, Siddu, Andrea, Saxentoff, Eugene, Stefanelli, Paola, "Retrospective Analysis of Six Years of Acute Flaccid Paralysis Surveillance and Polio Vaccine Coverage Reported by Italy, Serbia, Bosnia and Herzegovina, Montenegro, Bulgaria, Kosovo, Albania, North Macedonia, Malta, and Greece" in Vaccines, 10, no. 1 (2022):44,
https://doi.org/10.3390/vaccines10010044 . .

TY  - JOUR
AU  - Dente, Maria Grazia
AU  - Riccardo, Flavia
AU  - Bolici, Francesco
AU  - Colella, Nello Augusto
AU  - Jovanović, Verica
AU  - Drakulović, Mitra
AU  - Vasić, Milena
AU  - Mamlouk, Habiba
AU  - Maazaoui, Latifa
AU  - Bejaoui, Mondher
AU  - Zakhashvili, Khatuna
AU  - Kalandadze, Irine
AU  - Imnadze, Paata
AU  - Declich, Silvia
AU  - Knjeginić, Vesna
AU  - Stojković, Borka
AU  - Labus, Tatjana
AU  - Milicević, Vesna
AU  - Veljović, Ljubiša
AU  - Maksimović-Zorić, Jelena
AU  - Stoiljković, Vera
AU  - Filipović-Vignjević, Svetlana
AU  - Protić, Jelena
AU  - Zgomba, Marija
AU  - Petrić, Dusan
AU  - Despot, Dragana
AU  - Pesić, Branislav
AU  - Serović, Katarina
AU  - Aleksić, Ivan
AU  - Đurić, Ivana
AU  - Ilić, Dragan
AU  - Vrga, Svetlana
AU  - Pavlović, Ljiljana
AU  - Plavsa, Dragana
AU  - Grego, Edita
AU  - Harabech, Kaouther
AU  - Ben Alaya, Nissaf
AU  - Bougatef, Souha
AU  - Triki, Henda
AU  - Bouattour, Ali
AU  - Rebhi, Mohamed
AU  - Daaboub, Jabeur
AU  - Somai, Lamia
AU  - Zerlli, Malek
AU  - Zerlli, Malek
AU  - Oukaili, Kaouther
AU  - Ammar, Heni Haj
AU  - Sghaier, Chedia
AU  - Fatnassi, Naouel
AU  - Kalthoum, Sana
AU  - Dhaouadi, Anissa
AU  - Ben Youness, Abdelhak
AU  - Mahale, Issam
AU  - Marzouk, Mongi
AU  - Ben Bdira, Sassi
AU  - Grira, Samia
AU  - Ayadi, Sonia
AU  - Mastouri, Maha
AU  - Faten, Allad
AU  - Abdelkader, Ben
AU  - Chakhunashvili, Giorgi
AU  - Babuadze, Giorgi
AU  - Mamuchishvili, Nana
AU  - Chanturia, Gvantsa
AU  - Adeishvili, Ekaterine
AU  - Avaliani, Lasha
AU  - Ninidze, Lena
AU  - Kartskhia, Natia
AU  - Gulbani, Ana
AU  - Kokhreidze, Maka
AU  - Donduashvili, Marina
AU  - Kekelidze, Anna
PY  - 2019
UR  - http://intor.torlakinstitut.com/handle/123456789/535
AB  - Background In the Mediterranean and Black Sea Region, arbovirus infections are emerging infectious diseases. Their surveillance can benefit from one health inter-sectoral collaboration; however, no standardized methodology exists to study One Health surveillance. Methods We designed a situation analysis study to document how integration of laboratory/clinical human, animal and entomological surveillance of arboviruses was being implemented in the Region. We applied a framework designed to assess three levels of integration: policy/institutional, data collection/data analysis and dissemination. We tested the use of Business Process Modelling Notation (BPMN) to graphically present evidence of inter-sectoral integration. Results Serbia, Tunisia and Georgia participated in the study. West Nile Virus surveillance was analysed in Serbia and Tunisia, Crimea-Congo Haemorrhagic Fever surveillance in Georgia. Our framework enabled a standardized analysis of One Health surveillance integration, and BPMN was easily understandable and conducive to detailed discussions among different actors/institutions. In all countries, we observed integration across sectors and levels except in data collection and data analysis. Data collection was interoperable only in Georgia without integrated analysis. In all countries, surveillance was mainly oriented towards outbreak response, triggered by an index human case. Discussion The three surveillance systems we observed prove that integrated surveillance can be operationalized with a diverse spectrum of options. However, in all countries, the integrated use of data for early warning and inter-sectoral priority setting is pioneeristic. We also noted that early warning before human case occurrence is recurrently not operationally prioritized.
PB  - Wiley, Hoboken
T2  - Zoonoses and Public Health
T1  - Implementation of the One Health approach to fight arbovirus infections in the Mediterranean and Black Sea Region: Assessing integrated surveillance in Serbia, Tunisia and Georgia
EP  - 287
IS  - 3
SP  - 276
VL  - 66
DO  - 10.1111/zph.12562
ER  - 

@article{
author = "Dente, Maria Grazia and Riccardo, Flavia and Bolici, Francesco and Colella, Nello Augusto and Jovanović, Verica and Drakulović, Mitra and Vasić, Milena and Mamlouk, Habiba and Maazaoui, Latifa and Bejaoui, Mondher and Zakhashvili, Khatuna and Kalandadze, Irine and Imnadze, Paata and Declich, Silvia and Knjeginić, Vesna and Stojković, Borka and Labus, Tatjana and Milicević, Vesna and Veljović, Ljubiša and Maksimović-Zorić, Jelena and Stoiljković, Vera and Filipović-Vignjević, Svetlana and Protić, Jelena and Zgomba, Marija and Petrić, Dusan and Despot, Dragana and Pesić, Branislav and Serović, Katarina and Aleksić, Ivan and Đurić, Ivana and Ilić, Dragan and Vrga, Svetlana and Pavlović, Ljiljana and Plavsa, Dragana and Grego, Edita and Harabech, Kaouther and Ben Alaya, Nissaf and Bougatef, Souha and Triki, Henda and Bouattour, Ali and Rebhi, Mohamed and Daaboub, Jabeur and Somai, Lamia and Zerlli, Malek and Zerlli, Malek and Oukaili, Kaouther and Ammar, Heni Haj and Sghaier, Chedia and Fatnassi, Naouel and Kalthoum, Sana and Dhaouadi, Anissa and Ben Youness, Abdelhak and Mahale, Issam and Marzouk, Mongi and Ben Bdira, Sassi and Grira, Samia and Ayadi, Sonia and Mastouri, Maha and Faten, Allad and Abdelkader, Ben and Chakhunashvili, Giorgi and Babuadze, Giorgi and Mamuchishvili, Nana and Chanturia, Gvantsa and Adeishvili, Ekaterine and Avaliani, Lasha and Ninidze, Lena and Kartskhia, Natia and Gulbani, Ana and Kokhreidze, Maka and Donduashvili, Marina and Kekelidze, Anna",
year = "2019",
abstract = "Background In the Mediterranean and Black Sea Region, arbovirus infections are emerging infectious diseases. Their surveillance can benefit from one health inter-sectoral collaboration; however, no standardized methodology exists to study One Health surveillance. Methods We designed a situation analysis study to document how integration of laboratory/clinical human, animal and entomological surveillance of arboviruses was being implemented in the Region. We applied a framework designed to assess three levels of integration: policy/institutional, data collection/data analysis and dissemination. We tested the use of Business Process Modelling Notation (BPMN) to graphically present evidence of inter-sectoral integration. Results Serbia, Tunisia and Georgia participated in the study. West Nile Virus surveillance was analysed in Serbia and Tunisia, Crimea-Congo Haemorrhagic Fever surveillance in Georgia. Our framework enabled a standardized analysis of One Health surveillance integration, and BPMN was easily understandable and conducive to detailed discussions among different actors/institutions. In all countries, we observed integration across sectors and levels except in data collection and data analysis. Data collection was interoperable only in Georgia without integrated analysis. In all countries, surveillance was mainly oriented towards outbreak response, triggered by an index human case. Discussion The three surveillance systems we observed prove that integrated surveillance can be operationalized with a diverse spectrum of options. However, in all countries, the integrated use of data for early warning and inter-sectoral priority setting is pioneeristic. We also noted that early warning before human case occurrence is recurrently not operationally prioritized.",
publisher = "Wiley, Hoboken",
journal = "Zoonoses and Public Health",
title = "Implementation of the One Health approach to fight arbovirus infections in the Mediterranean and Black Sea Region: Assessing integrated surveillance in Serbia, Tunisia and Georgia",
pages = "287-276",
number = "3",
volume = "66",
doi = "10.1111/zph.12562"
}

Dente, M. G., Riccardo, F., Bolici, F., Colella, N. A., Jovanović, V., Drakulović, M., Vasić, M., Mamlouk, H., Maazaoui, L., Bejaoui, M., Zakhashvili, K., Kalandadze, I., Imnadze, P., Declich, S., Knjeginić, V., Stojković, B., Labus, T., Milicević, V., Veljović, L., Maksimović-Zorić, J., Stoiljković, V., Filipović-Vignjević, S., Protić, J., Zgomba, M., Petrić, D., Despot, D., Pesić, B., Serović, K., Aleksić, I., Đurić, I., Ilić, D., Vrga, S., Pavlović, L., Plavsa, D., Grego, E., Harabech, K., Ben Alaya, N., Bougatef, S., Triki, H., Bouattour, A., Rebhi, M., Daaboub, J., Somai, L., Zerlli, M., Zerlli, M., Oukaili, K., Ammar, H. H., Sghaier, C., Fatnassi, N., Kalthoum, S., Dhaouadi, A., Ben Youness, A., Mahale, I., Marzouk, M., Ben Bdira, S., Grira, S., Ayadi, S., Mastouri, M., Faten, A., Abdelkader, B., Chakhunashvili, G., Babuadze, G., Mamuchishvili, N., Chanturia, G., Adeishvili, E., Avaliani, L., Ninidze, L., Kartskhia, N., Gulbani, A., Kokhreidze, M., Donduashvili, M.,& Kekelidze, A.. (2019). Implementation of the One Health approach to fight arbovirus infections in the Mediterranean and Black Sea Region: Assessing integrated surveillance in Serbia, Tunisia and Georgia. in Zoonoses and Public Health
Wiley, Hoboken., 66(3), 276-287.
https://doi.org/10.1111/zph.12562

Dente MG, Riccardo F, Bolici F, Colella NA, Jovanović V, Drakulović M, Vasić M, Mamlouk H, Maazaoui L, Bejaoui M, Zakhashvili K, Kalandadze I, Imnadze P, Declich S, Knjeginić V, Stojković B, Labus T, Milicević V, Veljović L, Maksimović-Zorić J, Stoiljković V, Filipović-Vignjević S, Protić J, Zgomba M, Petrić D, Despot D, Pesić B, Serović K, Aleksić I, Đurić I, Ilić D, Vrga S, Pavlović L, Plavsa D, Grego E, Harabech K, Ben Alaya N, Bougatef S, Triki H, Bouattour A, Rebhi M, Daaboub J, Somai L, Zerlli M, Zerlli M, Oukaili K, Ammar HH, Sghaier C, Fatnassi N, Kalthoum S, Dhaouadi A, Ben Youness A, Mahale I, Marzouk M, Ben Bdira S, Grira S, Ayadi S, Mastouri M, Faten A, Abdelkader B, Chakhunashvili G, Babuadze G, Mamuchishvili N, Chanturia G, Adeishvili E, Avaliani L, Ninidze L, Kartskhia N, Gulbani A, Kokhreidze M, Donduashvili M, Kekelidze A. Implementation of the One Health approach to fight arbovirus infections in the Mediterranean and Black Sea Region: Assessing integrated surveillance in Serbia, Tunisia and Georgia. in Zoonoses and Public Health. 2019;66(3):276-287.
doi:10.1111/zph.12562 .

Dente, Maria Grazia, Riccardo, Flavia, Bolici, Francesco, Colella, Nello Augusto, Jovanović, Verica, Drakulović, Mitra, Vasić, Milena, Mamlouk, Habiba, Maazaoui, Latifa, Bejaoui, Mondher, Zakhashvili, Khatuna, Kalandadze, Irine, Imnadze, Paata, Declich, Silvia, Knjeginić, Vesna, Stojković, Borka, Labus, Tatjana, Milicević, Vesna, Veljović, Ljubiša, Maksimović-Zorić, Jelena, Stoiljković, Vera, Filipović-Vignjević, Svetlana, Protić, Jelena, Zgomba, Marija, Petrić, Dusan, Despot, Dragana, Pesić, Branislav, Serović, Katarina, Aleksić, Ivan, Đurić, Ivana, Ilić, Dragan, Vrga, Svetlana, Pavlović, Ljiljana, Plavsa, Dragana, Grego, Edita, Harabech, Kaouther, Ben Alaya, Nissaf, Bougatef, Souha, Triki, Henda, Bouattour, Ali, Rebhi, Mohamed, Daaboub, Jabeur, Somai, Lamia, Zerlli, Malek, Zerlli, Malek, Oukaili, Kaouther, Ammar, Heni Haj, Sghaier, Chedia, Fatnassi, Naouel, Kalthoum, Sana, Dhaouadi, Anissa, Ben Youness, Abdelhak, Mahale, Issam, Marzouk, Mongi, Ben Bdira, Sassi, Grira, Samia, Ayadi, Sonia, Mastouri, Maha, Faten, Allad, Abdelkader, Ben, Chakhunashvili, Giorgi, Babuadze, Giorgi, Mamuchishvili, Nana, Chanturia, Gvantsa, Adeishvili, Ekaterine, Avaliani, Lasha, Ninidze, Lena, Kartskhia, Natia, Gulbani, Ana, Kokhreidze, Maka, Donduashvili, Marina, Kekelidze, Anna, "Implementation of the One Health approach to fight arbovirus infections in the Mediterranean and Black Sea Region: Assessing integrated surveillance in Serbia, Tunisia and Georgia" in Zoonoses and Public Health, 66, no. 3 (2019):276-287,
https://doi.org/10.1111/zph.12562 . .